The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics-Reference-Cited by-同舟云学术

The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics

Published:2023-03-20 Issue:5 Volume:7 Page:340-354
ISSN:2397-3358
Container-title:Nature Reviews Chemistry
language:en
Short-container-title:Nat Rev Chem

Author:

Singh Vinayak^ORCID,Dziwornu Godwin Akpeko^ORCID,Chibale Kelly^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Chemical Engineering,General Chemistry

Link

https://www.nature.com/articles/s41570-023-00472-3.pdf

Reference91 articles.

1. World Health Organization. Global tuberculosis report (WHO, 2022).

2. Segal, L. N. et al. Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients. Cell Host Microbe 21, 530–537.e4 (2017).

3. Ghajavand, H. et al. High prevalence of bedaquiline resistance in treatment-naive tuberculosis patients and verapamil effectiveness. Antimicrob. Agents Chemother. 63, e02530-18 (2019).

4. Nimmo, C. et al. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis. Lancet Microbe 1, e165–e174 (2020).

5. Villellas, C. et al. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline. J. Antimicrob. Chemother. 72, 684–690 (2017).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterium smegmatis MfpC is a GEF that regulates mfpA translationally to alter the fluoroquinolone efficacy;Communications Biology;2024-08-23

2. Model‐Informed Approaches to Optimizing Therapeutics in the African Patient Populations;Clinical Pharmacology & Therapeutics;2024-08-20

3. CRISPR Screening and Comparative LC‐MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis;Advanced Science;2024-08-20

4. Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1;Journal of Biological Chemistry;2024-08

5. Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance;Metabolites;2024-01-18